UniProtKB/Swiss-Prot P04156 : Variant p.Glu211Gln
Major prion protein
Gene: PRNP
Feedback ?
Variant information
Variant position:
211
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
LP/P [Disclaimer : Variants classification is intended for research purposes only, not for clinical and diagnostic use . The label disease variant is assigned according to literature reports on probable disease-association that can be based on theoretical reasons. This label must not be considered as a definitive proof for the pathogenic role of a variant. ]
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Glutamate (E) to Glutamine (Q) at position 211 (E211Q, p.Glu211Gln).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Change from medium size and acidic (E) to medium size and polar (Q)
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Variant description:
In CJD.
Any additional useful information about the variant.
Other resources:
Links to websites of interest for the variant.
Sequence information
Variant position:
211
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
253
The length of the canonical sequence.
Location on the sequence:
TTTKGENFTETDVKMMERVV
E QMCITQYERESQAYYQRGSS
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:
The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human TTTK--------GENFTETDV--KMMERVVE QMCITQYERESQAYYQ--RGSS
Gorilla TTTK--------GENFTETDV--KMMERVVE QMCITQYERE
TTTK--------GENFTETDI--KMMERVVE QMCITQYQRE
Rhesus macaque TTTK--------GENFTETDV--KMMERVVE QMCITQYEKE
Chimpanzee TTTK--------GENFTETDV--KMMERVVE QMCITQYERE
Mouse TTTK--------GENFTETDV--KMMERVVE QMCVTQYQKE
Rat TTTK--------GENFTETDV--KMMERVVE QMCVTQYQKE
Pig TTTK--------GENFTETDV--KMIERVVE QMCITQYQKE
Bovine TTTK--------GENFTETDI--KMMERVVE QMCITQYQRE
Rabbit TTTK--------GENFTETDI--KIMERVVE QMCITQYQQE
Goat TTTK--------GENFTETDI--KIMERVVE QMCITQYQRE
Sheep TTTK--------GENFTETDI--KIMERVVE QMCITQYQRE
Cat TTTK--------GENFTETDM--KIMERVVE QMCVTQYQKE
Chicken PAAKKNTSEAVAAANQTEVEMENKVVTKVIR EMCVQQYRE-
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
23 – 230
Major prion protein
Region
23 – 230
Interaction with GRB2, ERI3 and SYN1
Lipidation
230 – 230
GPI-anchor amidated serine
Glycosylation
197 – 197
N-linked (GlcNAc...) asparagine
Disulfide bond
179 – 214
Literature citations
Identification of three novel mutations (E196K, V203I, E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutzfeldt-Jakob disease phenotype.
Peoc'h K.; Manivet P.; Beaudry P.; Attane F.; Besson G.; Didier H.; Delasnerie-Laupretre N.; Laplanche J.-L.;
Hum. Mutat. 15:482-482(2000)
Cited for: VARIANTS CJD LYS-196; ILE-203 AND GLN-211;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.